Iambic Therapeutics Pursues IPO Amid Controversy Over Isomorphic Labs' High Valuation
GOOGL Alphabet Inc
$353.78 +0.30%
View chart & analysis → - 1Iambic Therapeutics plans to launch an IPO this week.
- 2Iambic's valuation at the top of the IPO price range is $900 million.
- 3Bloomberg reported that Isomorphic Labs is in early negotiations for new funding with a valuation of at least $40 billion.
So what's the key point?
Iambic Therapeutics is preparing to enter the stock market. There is debate regarding whether Isomorphic Labs is worth as much as $40 billion.
Source Axios · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.